Becton, Dickinson Aktie
226,86USD | 0,41USD | 0,18% |
WKN: 857675 / ISIN: US0758871091
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,83 |
The Vanguard Group, Inc. | 9,04 |
Vanguard Group, Inc. (Subfiler) | 8,74 |
State Street Corp. | 4,83 |
T Rowe Price Associates, Inc. (13F Subfiler) | 4,53 |
T. Rowe Price Associates, Inc. (IM) | 3,59 |
Vanguard Total Stock Market ETF | 3,16 |
T. Rowe Price Investment Management, Inc. | 3,08 |
BlackRock Fund Advisors | 2,87 |
Vanguard 500 Index Fund | 2,65 |
BlackRock Institutional Trust Co. NA | 2,18 |
Geode Capital Management LLC | 2,17 |
Morgan Stanley Investment Management Ltd. | 2,08 |
Generation Investment Management LLP | 2,06 |
T Rowe Price Capital Appreciation Fund | 2,04 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 72 000 | 75 000 | 77 000 | 73 000 | 74 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,24 | 0,27 | 0,25 | 0,27 | 0,27 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 8 969 | 8 838 | 8 141 | 8 676 | 10 468 |
Summe Anlagevermögen | 45 043 | 45 028 | 44 793 | 44 104 | 46 818 |
Summe Aktiva | 54 012 | 53 866 | 52 934 | 52 780 | 57 286 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 30 247 | 30 189 | 27 652 | 26 983 | 31 396 |
Summe Eigenkapital | 23 765 | 23 677 | 25 282 | 25 797 | 25 890 |
Summe Passiva | 54 012 | 53 866 | 52 934 | 52 780 | 57 286 |
Adresse
1 Becton Drive, 07417-1880 Franklin Lakes | |
Telefon | +1 (201) 847-6800 |
Internet | http://www.bd.com |
Management
Ami E. Simunovich
Chief Quality & Regulatory Officer, Executive VP |
Antoine Ezell
Chief Marketing Officer & EVP-North America |
Antoinette F. Segreto
Senior Vice President-Taxes |
Bertram L. Scott
Lead Independent Director |
Brooke Story
President-Integrated Diagnostic Solutions |
Carrie L. Byington
Independent Director |
Catherine M. Burzik
Independent Director |
Christopher Ian Montague Jones
Independent Director |
Christopher J. DelOrefice
Chief Financial & Accounting Officer, EVP |
Claire M. Fraser-Liggett
Independent Director |
Claudia Curtis
Chief Ethics & Compliance Officer, Senior VP |
David Shan
Chief Quality Officer & Executive Vice President |
Denise Russell Fleming
Chief Information Officer & EVP-Technology |
Ebonee Lewis
Chief Employment Counsel |
Elizabeth McCombs
Chief Technology Officer & Executive VP |
Gary Michael DeFazio
Secretary, Senior VP & Associate General Counsel |
Gregory Rodetis
Treasurer, Senior VP & Head-Investor Relations |
Jeffrey William Henderson
Independent Director |
Joanne Waldstreicher
Independent Director |
Joseph M. Smith
Chief Scientific Officer & Senior Vice President |
Michael Feld
Executive Vice President & President-Life Sciences |
Michelle Quinn
Executive Vice President & General Counsel |
Rishi Grover
Chief Integrated Supply Chain Officer & EVP |
Robert Andrew Eckert
Independent Director |
Ronald P. Silverman
Chief Medical Officer & Executive Vice President |
Shana Carol Neal
Chief People Officer & Executive Vice President |
Stephen O. Richard
Chief Risk Officer & Senior Vice President |
Thomas E. Polen
Chairman, President & Chief Executive Officer |
Thomas J. Spoerel
Senior Vice President & Controller |
Timothy M. Ring
Independent Director |
Vishy Kanda
Chief Strategy Officer & Senior Vice President |
William M. Brown
Independent Director |